I am delighted to announce that ABCD and the Primary Care Diabetes Society (PCDS) have formally agreed to collaborate in certain aspects of the nationwide audits of new diabetes therapies and devices.  The agreement was signed at the end of November by Dr Clare Hambling PCDS Chair and Dr Bob Ryder, Clinical lead, ABCD audits of new diabetes therapies and devices.  The collaboration will focus initially on collecting real world data on FreeStyle Libre in type 2 diabetes.  

Hybrid Closed Loop Therapy in Adults with Type 1 Diabetes and Above-Target HbA1c: A Real-World Observational Study

Members are very much encouraged to take part in our ongoing real world data collection from which we have learned so much (https://abcd.care/all-abcd-audit-publications).

ABCD nationwide FSL audit our first device audit

ABCD, YDEF and Lilly have partnered to provide a virtual education programme for specialists working in diabetes.

The Diabetes Masterclass Educational Series has been organised and funded by Eli Lilly & Company, developed in partnership with ABCD and YDEF.

The webinar series provides regular updates on relevant topics to support those delivering diabetes services. Watch the webinar on-demand below.

This audit is now completed though analysis of the data continues, and publications can be viewed here.

ABCD worldwide Omnipod audit

Presented by Dr Emma Wilmot